Počet záznamov: 1
ataxín-2
SYS d000067698 LBL 00000nz--a2200181n--4500 005 20250606221730.0 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D12.776.157.725.452.125 065 $a D12.776.631.069.750 065 $a D12.776.660.075.750 065 $a D12.776.664.962.452.125 066 $a 01 $c 03 150 $a ataxín-2 $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a proteín ataxínu-2 $2 slo 450 $w v $a Atx-2 proteín $2 slo 450 $w v $a SCA2 proteín $2 slo 450 $w v $a proteín spinocerebelárnej ataxie typu 2 $2 slo 550 $7 sllk_us_auth*d020754 $Y Spinocerebellar Ataxias $w b $a ataxie spinocerebelárne 550 $7 sllk_us_auth*d020754 $Y Spinocerebellar Ataxias $w p $a ataxie spinocerebelárne 665 $a 2016; use SCA2 PROTEIN (NM) 1996-2015 $2 eng 665 $a Nerve Tissue Proteins (2005-2015) $2 eng 665 $a Proteins (1996-2005) $2 eng 680 9-
$i A Poly(A) RNA-binding protein that negatively regulates EGFR ENDOCYTOSIS. An increased risk for developing AMYOTROPHIC LATERAL SCLEROSIS 13 is observed in patients who have more than 23 CAG repeats in the ATXN2 gene coding sequence. Larger CAG expansions in the ATXN2 gene occur in SPINOCEREBELLAR ATAXIA 2 patients. $2 eng 750 -2
$a Ataxin-2 $2 eng 980 $x M
Počet záznamov: 1